Matches in Wikidata for { <http://www.wikidata.org/entity/Q66410711> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q66410711 description "assaig clínic" @default.
- Q66410711 description "clinical trial" @default.
- Q66410711 description "clinical trial" @default.
- Q66410711 description "clinical trial" @default.
- Q66410711 description "clinical trial" @default.
- Q66410711 description "ensaio clínico" @default.
- Q66410711 description "ensayo clínico" @default.
- Q66410711 description "ensayu clínicu" @default.
- Q66410711 description "essai clinique" @default.
- Q66410711 description "klinisch onderzoek" @default.
- Q66410711 description "клінічне випробування" @default.
- Q66410711 name "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)" @default.
- Q66410711 name "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus" @default.
- Q66410711 type Item @default.
- Q66410711 label "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)" @default.
- Q66410711 label "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus" @default.
- Q66410711 prefLabel "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)" @default.
- Q66410711 prefLabel "Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus" @default.
- Q66410711 P1132 Q66410711-6D7AB0AD-D1C0-42BC-9120-7F48D3B14AA5 @default.
- Q66410711 P1476 Q66410711-7AD93182-3704-4EFA-996C-094EAC06542E @default.
- Q66410711 P1813 Q66410711-FAA8933C-12E5-47CA-AC75-27C88AFAE8FD @default.
- Q66410711 P2899 Q66410711-BFE6C38F-E484-42CA-A22D-87C004B620AF @default.
- Q66410711 P3098 Q66410711-B691E108-A4B5-4C13-86FE-F2317D1CD637 @default.
- Q66410711 P31 Q66410711-4090F103-EDB2-4B5B-AC6E-08F6A3531B2D @default.
- Q66410711 P580 Q66410711-15A3D2B6-7FFA-44F7-9361-6F362997B291 @default.
- Q66410711 P582 Q66410711-592FAE78-6A7D-4983-ABEE-3515DB8876C0 @default.
- Q66410711 P6099 Q66410711-B8D681AD-B4D9-407C-94DC-37844BBF1599 @default.
- Q66410711 P8363 Q66410711-F0DAD8EF-5391-44E5-A798-C14F6E26714A @default.
- Q66410711 P1132 "+10" @default.
- Q66410711 P1476 "A Phase IIa Multicenter, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A in Treatment-Naïve HIV-1 Infected Subjects With Selected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Transmitted Resistance Mutations" @default.
- Q66410711 P1813 "DRIVE BEYOND" @default.
- Q66410711 P2899 "+18" @default.
- Q66410711 P3098 "NCT02629822" @default.
- Q66410711 P31 Q30612 @default.
- Q66410711 P580 "2016-01-14T00:00:00Z" @default.
- Q66410711 P582 "2018-11-28T00:00:00Z" @default.
- Q66410711 P6099 Q42824440 @default.
- Q66410711 P8363 Q78089383 @default.